VRTX

Vertex Pharmaceuticals Incorporated (VRTX)

Last Price$409.9(0.5%)
Market Cap$105.0B
LTM Gross margin
86.1%
5Y avg
87.6%
Biotechnology industry median
65.9%
Stock quality & Intrinsic value
6/10
(0.1%) overvalued

Vertex Pharmaceuticals Incorporated Gross margin

Annual
Quarterly
LTM
Industry median
Company stand-alone
VRTX
Healthcare
Crunching data... Almost there!
Dec'04Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
Gross margin
94.5%
93.7%
94.4%
93.0%
91.1%
86.1%
91.1%
94.3%
81.7%
89.3%
89.5%
87.8%
87.6%
88.9%
86.6%
86.8%
88.1%
88.1%
87.9%
87.2%
VRTX
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for VRTX and see if it's the right time to invest.
Dive in

Vertex Pharmaceuticals Incorporated (VRTX) Gross margin comparison analysis

Crunching data... Almost there!

VRTX key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!

Discover more Stock Ideas

Loved by
investors
worldwide
10K+
Investors use our platform
#1
Top value investing hub with all necessary tools
1K+
Experienced investors in our community
4.9
Average rating across all rating platforms

FAQ

1) What is Vertex Pharmaceuticals Incorporated's Gross margin?

As of today, Microsoft Corp's last 12-month Gross margin is 86.1%, based on the financial report for Sep 30, 2024 (Q3 2024). The average annual Gross margin for Vertex Pharmaceuticals Incorporated have been 87.6% over the past three years, and 91.9% over the past five years.

2) Is Vertex Pharmaceuticals Incorporated's Gross margin Good?

As of today, Vertex Pharmaceuticals Incorporated's Gross margin is 86.1%, which is higher than industry median of 65.9%. It indicates that Vertex Pharmaceuticals Incorporated's Gross margin is Good.

3) How does Vertex Pharmaceuticals Incorporated's Gross margin compare to its peers?

As of today, Vertex Pharmaceuticals Incorporated's Gross margin is 86.1%, which is higher than peer median of 85.0%. The list of peers includes GMAB, INCY, UTHR, ARGX, ALNY, NVO, REGN, BNTX, BGNE, MRNA.